262 related articles for article (PubMed ID: 29027595)
21. Carnosinase concentration, activity, and CNDP1 genotype in patients with type 2 diabetes with and without nephropathy.
Zhang S; Albrecht T; Rodriguez-Niño A; Qiu J; Schnuelle P; Peters V; Schmitt CP; van den Born J; Bakker SJL; Lammert A; Krämer BK; Yard BA; Hauske SJ
Amino Acids; 2019 Apr; 51(4):611-617. PubMed ID: 30610469
[TBL] [Abstract][Full Text] [Related]
22. Homocarnosinosis: lack of serum carnosinase is the defect probably responsible for elevated brain and CSF homocarnosine.
Lenney JF; Peppers SC; Kucera CM; Sjaastad O
Clin Chim Acta; 1983 Aug; 132(2):157-65. PubMed ID: 6616870
[TBL] [Abstract][Full Text] [Related]
23. The influence of carnosinase gene polymorphisms on diabetic nephropathy risk in African-Americans.
McDonough CW; Hicks PJ; Lu L; Langefeld CD; Freedman BI; Bowden DW
Hum Genet; 2009 Aug; 126(2):265-75. PubMed ID: 19373489
[TBL] [Abstract][Full Text] [Related]
24. Carnosine treatment in combination with ACE inhibition in diabetic rats.
Peters V; Riedl E; Braunagel M; Höger S; Hauske S; Pfister F; Zschocke J; Lanthaler B; Benck U; Hammes HP; Krämer BK; Schmitt CP; Yard BA; Köppel H
Regul Pept; 2014 Nov; 194-195():36-40. PubMed ID: 25234296
[TBL] [Abstract][Full Text] [Related]
25. Sequence identification and characterization of human carnosinase and a closely related non-specific dipeptidase.
Teufel M; Saudek V; Ledig JP; Bernhardt A; Boularand S; Carreau A; Cairns NJ; Carter C; Cowley DJ; Duverger D; Ganzhorn AJ; Guenet C; Heintzelmann B; Laucher V; Sauvage C; Smirnova T
J Biol Chem; 2003 Feb; 278(8):6521-31. PubMed ID: 12473676
[TBL] [Abstract][Full Text] [Related]
26. Exploring the structural and dynamic differences between human carnosinase I (CN1) and II (CN2).
Tancharoen C; Tovivek B; Niramitranon J; Kityakarn S; Luksirikul P; Gorinstein S; Pongprayoon P
Proteins; 2023 Jun; 91(6):822-830. PubMed ID: 36637795
[TBL] [Abstract][Full Text] [Related]
27. Intrinsic carnosine metabolism in the human kidney.
Peters V; Klessens CQ; Baelde HJ; Singler B; Veraar KA; Zutinic A; Drozak J; Zschocke J; Schmitt CP; de Heer E
Amino Acids; 2015 Dec; 47(12):2541-50. PubMed ID: 26206726
[TBL] [Abstract][Full Text] [Related]
28. Carnosine and Kidney Diseases: What We Currently Know?
Kilis-Pstrusinska K
Curr Med Chem; 2020; 27(11):1764-1781. PubMed ID: 31362685
[TBL] [Abstract][Full Text] [Related]
29. [Serum carnosinase deficiency and homocarnosinosis].
Hamajima N; Wada Y
Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):252-4. PubMed ID: 9590040
[No Abstract] [Full Text] [Related]
30. Carnosinases, their substrates and diseases.
Bellia F; Vecchio G; Rizzarelli E
Molecules; 2014 Feb; 19(2):2299-329. PubMed ID: 24566305
[TBL] [Abstract][Full Text] [Related]
31. Influence of carnosine and carnosinase-1 on diabetes-induced afferent arteriole vasodilation: implications for glomerular hemodynamics.
Rodriguez-Niño A; Pastene DO; Hettler SA; Qiu J; Albrecht T; Vajpayee S; Perciaccante R; Gretz N; Bakker SJL; Krämer BK; Yard BA; van den Born J
Am J Physiol Renal Physiol; 2022 Jul; 323(1):F69-F80. PubMed ID: 35635322
[TBL] [Abstract][Full Text] [Related]
32. Does low serum carnosinase activity favor high-intensity exercise capacity?
Baguet A; Everaert I; Yard B; Peters V; Zschocke J; Zutinic A; De Heer E; Podgórski T; Domaszewska K; Derave W
J Appl Physiol (1985); 2014 Mar; 116(5):553-9. PubMed ID: 24408989
[TBL] [Abstract][Full Text] [Related]
33. Exclusion of polymorphisms in carnosinase genes (CNDP1 and CNDP2) as a cause of diabetic nephropathy in type 1 diabetes: results of large case-control and follow-up studies.
Wanic K; Placha G; Dunn J; Smiles A; Warram JH; Krolewski AS
Diabetes; 2008 Sep; 57(9):2547-51. PubMed ID: 18753673
[TBL] [Abstract][Full Text] [Related]
34. A polymorphism in the gene encoding carnosinase (CNDP1) as a predictor of mortality and progression from nephropathy to end-stage renal disease in type 1 diabetes mellitus.
Alkhalaf A; Bakker SJ; Bilo HJ; Gans RO; Navis GJ; Postmus D; Forsblom C; Groop PH; Vionnet N; Hadjadj S; Marre M; Parving HH; Rossing P; Tarnow L
Diabetologia; 2010 Dec; 53(12):2562-8. PubMed ID: 20711718
[TBL] [Abstract][Full Text] [Related]
35. Sex specific association between carnosinase gene CNDP1 and cardiovascular mortality in patients with type 2 diabetes (ZODIAC-22).
Alkhalaf A; Landman GW; van Hateren KJ; Groenier KH; Mooyaart AL; De Heer E; Gans RO; Navis GJ; Bakker SJ; Kleefstra N; Bilo HJ
J Nephrol; 2015 Apr; 28(2):201-7. PubMed ID: 24756973
[TBL] [Abstract][Full Text] [Related]
36. Re: Exclusion of polymorphisms in carnosinase genes (CNDP1 and CNDP2) as a cause of diabetic nephropathy in type 1 diabetes: results of large case-control and follow-up studies.
Bakker SJ; Alkhalaf A; Tarnow L; Navis G
Diabetes; 2008 Dec; 57(12):e16; author reply e17. PubMed ID: 19033401
[No Abstract] [Full Text] [Related]
37. Mechanistic insights on anserine hydrolyzing activities of human carnosinases.
Pandya VK; Shankar SS; Sonwane BP; Rajesh S; Rathore R; Kumaran S; Kulkarni MJ
Biochim Biophys Acta Gen Subj; 2023 Mar; 1867(3):130290. PubMed ID: 36529243
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of functional dipeptide carnosine from nonprotected amino acids using carnosinase-displaying yeast cells.
Inaba C; Higuchi S; Morisaka H; Kuroda K; Ueda M
Appl Microbiol Biotechnol; 2010 May; 86(6):1895-902. PubMed ID: 20082075
[TBL] [Abstract][Full Text] [Related]
39. The influence of a single nucleotide polymorphism within CNDP1 on susceptibility to diabetic nephropathy in Japanese women with type 2 diabetes.
Kurashige M; Imamura M; Araki S; Suzuki D; Babazono T; Uzu T; Umezono T; Toyoda M; Kawai K; Imanishi M; Hanaoka K; Maegawa H; Uchigata Y; Hosoya T; Maeda S
PLoS One; 2013; 8(1):e54064. PubMed ID: 23342076
[TBL] [Abstract][Full Text] [Related]
40. Anserine and Carnosine Induce HSP70-Dependent H
Wetzel C; Pfeffer T; Bulkescher R; Zemva J; Modafferi S; Polimeni A; Salinaro AT; Calabrese V; Schmitt CP; Peters V
Antioxidants (Basel); 2022 Dec; 12(1):. PubMed ID: 36670928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
